Results 171 to 180 of about 477,806 (337)
Kisspeptin as a test of hypothalamic dysfunction in pubertal and reproductive disorders
Abstract The hypothalamic–pituitary–gonadal axis is regulated by the gonadotropin‐releasing hormone pulse generator in the hypothalamus. This is comprised of neurons that secrete kisspeptin in a pulsatile manner to stimulate the release of GnRH, and, in turn, downstream gonadotropins from the pituitary gland, and subsequently sex steroids and ...
Aureliane C. S. Pierret +5 more
wiley +1 more source
Adrenal cortex development and related disorders leading to adrenal insufficiency
Emanuele Pignatti, C. Flück
semanticscholar +1 more source
Abstract This report is the transcript of what was discussed in a convention at the Endocrinology Unit in Modena, Italy, in the form of the aporetic dialogs of ancient Greece. It is the third episode of a series of four discussions on the differences between males and females, with a multidisciplinary approach. In this work, the role of testosterone in
Giulia Brigante +6 more
wiley +1 more source
Adrenal crisis in infants and young children with adrenal insufficiency: Management and prevention [PDF]
Carla Bizzarri +5 more
openalex +1 more source
Adrenal insufficiency in a child following unilateral excision of a dual-hormone secreting phaeochromocytoma [PDF]
Annika Sjoeholm +6 more
openalex +1 more source
Mutations in sphingosine-1-phosphate lyase cause nephrosis with ichthyosis and adrenal insufficiency [PDF]
Connolly, Anne M +4 more
core +2 more sources
Antimicrobial prescribing guidelines for horses in Australia
The growing problem of antimicrobial resistance also affects equine veterinarians with increasing frequency. Antimicrobial stewardship and responsible prescribing are essential for a future in which effective antimicrobials are available, as it is unlikely that new antimicrobials will become available for use in horses.
L Hardefeldt +18 more
wiley +1 more source
Summary The efficacy of ciclosporin (CsA) to treat transfusion‐independent non‐severe aplastic anaemia (TI‐NSAA) has not yet been systematically evaluated. We conducted a prospective trial in patients with TI‐NSAA treated with CsA monotherapy. CsA (3.5 mg/kg/day) was administered to patients with TI‐NSAA aged ≥16.
Ken Ishiyama +14 more
wiley +1 more source

